Indivior (NASDAQ:INDV) Shares Gap Down to $17.05

Indivior PLC (NASDAQ:INDV)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $17.05, but opened at $16.60. Indivior shares last traded at $16.84, with a volume of 5,519 shares traded.

Wall Street Analyst Weigh In

Separately, Craig Hallum began coverage on Indivior in a report on Wednesday, April 3rd. They issued a “buy” rating and a $37.00 price target for the company.

Indivior Stock Performance

The company has a quick ratio of 0.74, a current ratio of 0.92 and a debt-to-equity ratio of 23.50. The firm has a market capitalization of $2.33 billion, a P/E ratio of 1,705.00 and a beta of 0.63. The stock has a fifty day moving average of $19.36 and a 200-day moving average of $18.05.

Indivior (NASDAQ:INDV) last posted its quarterly earnings data on Thursday, April 25th. The company reported $0.37 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.38 by ($0.01). Indivior had a return on equity of 842.72% and a net margin of 0.44%. The firm had revenue of $284.00 million for the quarter, compared to the consensus estimate of $300.00 million. On average, research analysts anticipate that Indivior PLC will post 2 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of the stock. Scopia Capital Management LP acquired a new position in Indivior during the third quarter valued at approximately $191,743,000. Vanguard Group Inc. boosted its position in Indivior by 0.9% during the fourth quarter. Vanguard Group Inc. now owns 5,899,190 shares of the company’s stock valued at $90,081,000 after purchasing an additional 52,836 shares during the last quarter. FMR LLC lifted its position in shares of Indivior by 53.5% in the third quarter. FMR LLC now owns 5,498,087 shares of the company’s stock valued at $119,339,000 after buying an additional 1,915,980 shares during the last quarter. Norges Bank acquired a new stake in shares of Indivior in the fourth quarter valued at approximately $36,011,000. Finally, Toronto Dominion Bank lifted its position in shares of Indivior by 58.0% in the first quarter. Toronto Dominion Bank now owns 2,094,865 shares of the company’s stock valued at $44,872,000 after buying an additional 769,000 shares during the last quarter. 60.33% of the stock is owned by institutional investors and hedge funds.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.